Medicus Pharma News

Express News | Medicus Pharma Shares Are Trading Higher After the Company Its INAD File No.013880 Was Used as Part of a Major Species Designation From the FDA

BenzingaDec 12 08:27 ET

Medicus Pharma up 9% in Pre-market Trading as FDA Approves Anti-cancer Patch for Horses

MT NewswiresDec 12 08:18 ET

Medicus Pharma Eyes Veterinary Market With FDA Designation

TipRanksDec 12 08:07 ET

Express News | Medicus Pharma Says INAD File No.013880 Received Minor Use In Major Species Designation From FDA For Its Dissolvable D-MNA To Treat External Squamous Cell Carcinoma In Horses

BenzingaDec 12 07:47 ET

Medicus Pharma Announcs Its INAD Received MUMS From U.S. FDA

TipRanksDec 12 07:36 ET

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation From the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

newsfileDec 12 07:30 ET

Medicus Pharma Eyes Pivotal Trial for Novel Skin Cancer Therapy as Phase 2 Enrollment Progresses | TSX-V:MDCX, NASDAQ:MDCX

Proactive InvestorsDec 2 14:44 ET

Medicus Pharma Enters Collaboration Agreement With Swanielle

TipRanksDec 2 07:40 ET

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

newsfileDec 2 07:30 ET

Medicus Pharma Ltd. Expands With Strategic Takeover

TipRanksNov 25 08:30 ET

6-K: Report of foreign private issuer (related to financial reporting)

SECNov 25 08:02 ET · Announcements

Medicus Pharma Unveils Ex-GSK and Pfizer Senior as Chief Medical Officer | TSX-V:MDCX, NASDAQ:MDCX

Proactive InvestorsNov 18 08:44 ET

Leadership Changes at Medicus Pharma Ltd

TipRanksNov 18 08:10 ET

Press Release: Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Dow JonesNov 18 07:30 ET

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 02:13 ET

Medicus Pharma Shares Fall After IPO

WSJNov 14 14:26 ET

Medicus Pharma CEO Dr Raza Bokhari on $4M Nasdaq IPO & Phase 2 Trial | TSX-V:MDCX, NASDAQ:MDCX

Proactive InvestorsNov 14 14:11 ET

Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States

newsfileNov 13 18:45 ET

Medicus Pharma Ltd. Announces Share Consolidation in Anticipation of Proposed U.S. Listing

newsfileOct 28 12:28 ET

Medicus Pharma Ltd.: Files for IPO, Intends to Apply to List Common Shares and Warrants on a U.S. Exchange Under Symbols 'MDCX' and 'MDCXW,' Respectively

Dow JonesJul 15 17:59 ET